Endogenous Morphine or a Naturally Occurring Metabolite Thereof as a Marker for Infection
AssigneeJustus-Liebig Universitat
InventorsYannick Goumon, Dominique Aunis, Marie-Helene Metz-Boutigue, Francis Schneider, Ingeborg Welters
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for detecting infection in a patient comprising measuring the concentration of endogenous morphine or a naturally occurring metabolite thereof in a biological sample obtained from said patient.
Claims12
A method for detecting infection in a patient, said method comprising detecting endogenous morphine or a naturally occurring metabolite thereof in a biological sample obtained from said patient.
A method for detecting sepsis in a patient, said method comprising detecting endogenous morphine or a naturally occurring metabolite thereof in a biological sample obtained from said patient.
A method for detecting sepsis in a patient, said method comprising measuring the concentration of endogenous morphine or a naturally occurring metabolite thereof in a biological sample obtained from said patient.
9-12. (canceled)
A kit comprising a binding partner which selectively interacts with morphine or a naturally occurring metabolite thereof and at least one antibody selected from the group consisting of an anti-C-reactive Protein (CRP) antibody and an anti-procalcitonin antibody.
Dependencies are inferred from the claim text.